genetics

R&D

Harnessing genetics to propel cancer research and clinical s...

When navigating the landscape of pharmaceutical development, clinical trials represent both a crucial checkpoint and a formidable barrier.

R&D

an old woman and her middle-aged daughter image for a feature on ageing and neurological conditions

Ageing Europe - It’s time we prioritised neurological condit...

Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy

R&D

Applying genetics to chemistry to find new small molecules

For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science.

R&D

Data-driven disease research harnessing the genome

Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.

News

23andMe doses first patient in ph2a anti-tumour monotherapy

Additionally, the company will be making investor presentations today and next week.

R&D

Why early participant engagement is now a top priority in ge...

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in ser